Evolution of estimated glomerular filtration rate in HIV/HCV-coinfected patients who received direct-acting antivirals: A multicenter retrospective study

Tsai, Ching-YenChing-YenTsaiChen, Guan-JhouGuan-JhouChenTsai, Chin-ShiangChin-ShiangTsaiLiou, Bo-HuangBo-HuangLiouYang, Chia-JuiChia-JuiYangTsai, Hung-ChinHung-ChinTsaiLin, Chi-YingChi-YingLinHuang, Sung-HsiSung-HsiHuangKUAN-YIN LINWang, Ning-ChiNing-ChiWangChen, Tun-ChiehTun-ChiehChenLee, Chen-HsiangChen-HsiangLeeCHIEN-CHING HUNG2023-05-032023-05-032023-03-3116841182https://scholars.lib.ntu.edu.tw/handle/123456789/630700The short-term impact of sofosbuvir (SOF)-based direct-acting antivirals (DAAs) combined with antiretroviral therapy (ART) on renal function in patients with HIV/HCV-coinfection remains controversial.enAcute kidney disease; Ageing; Renal function; Sofosbuvir; TenofovirEvolution of estimated glomerular filtration rate in HIV/HCV-coinfected patients who received direct-acting antivirals: A multicenter retrospective studyjournal article10.1016/j.jmii.2023.03.009370456342-s2.0-85152270553https://api.elsevier.com/content/abstract/scopus_id/85152270553